PER
Click for more information
0.00% 8.0¢ percheron therapeutics limited

target, page-6

  1. faimac
    9 Posts.
    clock Created with Sketch.
    28/02/08
    10:01
    Post #: 3405539
    Elan, Biogen slide on Tysabri warning
    By Val Brickates Kennedy, MarketWatch
    Last update: 2:46 p.m. EST Feb. 27, 2008
    BOSTON (MarketWatch) - Shares of partners Elan Corp. and Biogen Idec were trending downward Wednesday afternoon, following news that the Food and Drug Administration has issued a new safety warning about its multiple sclerosis drug Tysabri.



    sigh
    ANP Price at posting: 0.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

HIQ HITIQ's sensor-containing mouthguard OK'd by World Rugby specifications board
right-arrow Created with Sketch.
NRX Noronex joins forces with South32 to look for copper in Namibia
right-arrow Created with Sketch.
ASL Andean discovers up to 4,649 AgEq through maiden drilling in Chile
right-arrow Created with Sketch.
FMG Andrew Forrest was seemingly possessed by the spirit of hydrogen – now he's cut 700 jobs and canned FFI
right-arrow Created with Sketch.
AMI First stope ore could be pushed back to Q2 FY25 due to flood-like event: Aurelia
right-arrow Created with Sketch.
ABY Adore Beauty FY24 revenues up 7.4% YoY to $196M
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $72.12M
Open High Low Value Volume
7.9¢ 8.0¢ 7.9¢ $12.63K 158.7K

Buyers (Bids)

No. Vol. Price($)
2 66500 7.6¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 273231 2
View Market Depth
Last trade - 15.26pm 19/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.